Content about Pharmaceutical companies

June 20, 2011
Specialty Rx, diabetes to drive drug trend

The overall growth in drug spending for 2010 was 3.7%, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions. The lower increase 
was primarily due to higher rates of generic drug dispensing — more than 71% of drugs dispensed were generics. 


June 17, 2011
FDA rejects Teva's request to block Watson's generic Seasonique

A federal court has rejected Teva Pharmaceutical Industries’ efforts to prevent Watson from launching a generic version of one of its drugs, Watson said Friday.

June 16, 2011
Sanofi, Audion enter research collaboration for hearing loss treatments

French drug maker Sanofi has entered a collaboration with Audion Therapeutics to develop treatments for hearing loss.

June 15, 2011
Nasacort AQ generic enters market

Teva Pharmaceutical Industries has begun shipping a generic drug for allergies, partnering company Perrigo said Wednesday.

June 15, 2011
Tradjenta now available in U.S. pharmacies

A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

June 15, 2011
Watson confirms patent challenge for generic Pataday

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.

June 14, 2011
Bayer Advanced Aspirin officially launches

Bayer on Tuesday introduced its new Bayer Advanced Aspirin, billed as relieving pain “twice as fast” as the previous Extra Strength Bayer Aspirin.

June 14, 2011
FTC issues 'second request' to Teva, Cephalon over deal

Before they can move ahead with their deal, drug makers Teva and Cephalon must provide the Federal Trade Commission with additional information related to Teva's pending acquisition of Cephalon.

June 14, 2011
Report: GSK brands on sales block peak interest

GlaxoSmithKline has garnered strong interest in its portfolio of legacy brands that were placed on the sales block earlier this year, according to a Reuters report published Tuesday. And that interest is likely to pick up in the coming months, GSK CEO Andrew Witty told reporters during a meeting of pharmaceutical industry executives.

June 13, 2011
GSK, Valeant receive FDA approval for Potiga

The Food and Drug Administration has approved a new drug for epilepsy made by GlaxoSmithKline and Valeant Pharmaceuticals International, the drug makers said Monday.

June 13, 2011
Merck, Hanwha to develop Enbrel biosimilar

Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

June 13, 2011
PhRMA: More than 260 medicines in development to treat skin diseases

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

June 9, 2011
Court vacates Amylin restraining order against Eli Lilly

A federal court has ruled in favor of drug maker Eli Lilly & Co. in a dispute with Amylin Pharmaceuticals over Lilly’s partnership with German drug maker Boehringer Ingelheim.

June 8, 2011
Sandoz launches Syeda

The Food and Drug Administration has approved a generic oral contraceptive made by Sandoz, the company said Wednesday.

June 7, 2011
Actavis granted final approval for generic Ambien CR

The Food and Drug Administration has given final approval to a generic drug for insomnia made by Actavis, the drug maker said Monday.

June 7, 2011
Dr. Reddy's gets OK for three drugs

Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.

June 7, 2011
HDMA announces 2011 DIANA winners

The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.

June 7, 2011
Mylan subsidiary gets OK for generic Aricept

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

June 6, 2011
12 generic versions of Femara in market, FDA reports

The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.

June 2, 2011
Teva's generic Aricept OKed by FDA

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

June 1, 2011
Actavis' generic Aricept gets FDA nod

The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.

June 1, 2011
Sandoz gets green light for two generic Alzheimer's disease drugs

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

May 26, 2011
Teva to market generic Combivir tablets

Teva Pharmaceutical Industries is set to market a generic version of an HIV treatment, the drug maker announced Thursday.

May 25, 2011
Watson acquires Specifar

Watson Pharmaceuticals has acquired Greek drug maker Specifar Pharmaceuticals for $562 million, the two companies said Wednesday.

May 24, 2011
Lilly inks deal with Care Capital, NovaQuest Capital to establish BioCritica

Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

© 2013 Drug Store News. All Rights Reserved.